Novartis AG
Utility Patent Applications

Last updated:

List of all Novartis AG patents 676 in total

Status Patent
Application
Utility: NEEDLE EJECTION AND RETRACTION MECHANISM AND INJECTOR DEVICE External link
Filling date: 23 Sep 2025 Issue date: 9 Apr 2020
Application
Utility: COMBINATION THERAPY External link
Filling date: 23 Sep 2025 Issue date: 2 Apr 2020
Application
Utility: NEW METHODS FOR THE TREATMENT OF MULTIPLE SCLEROSIS External link
Filling date: 23 Sep 2025 Issue date: 26 Mar 2020
Application
Utility: COMBINATION OF CERTINIB WITH AN EGFR INHIBITOR External link
Filling date: 23 Sep 2025 Issue date: 19 Mar 2020
Application
Utility: Methods of Treating Palmoplantar Pustular Psoriasis (PPP) Using IL-17 Antagonists External link
Filling date: 23 Sep 2025 Issue date: 19 Mar 2020
Application
Utility: THERAPEUTIC REGIMENS FOR CHIMERIC ANTIGEN RECEPTOR THERAPIES External link
Filling date: 23 Sep 2025 Issue date: 19 Mar 2020
Application
Utility: SILENT Fc VARIANTS OF ANTI-CD40 ANTIBODIES External link
Filling date: 23 Sep 2025 Issue date: 19 Mar 2020
Application
Utility: BIOMARKERS AND CAR T CELL THERAPIES WITH ENHANCED EFFICACY External link
Filling date: 23 Sep 2025 Issue date: 19 Mar 2020
Application
Utility: CALCULATION OF ACTUAL ASTIGMATISM CORRECTION AND NOMOGRAPHS FOR CORNEAL LASER TREATMENT External link
Filling date: 23 Sep 2025 Issue date: 19 Mar 2020
Application
Utility: METHODS OF TREATING FGF21-ASSOCIATED DISORDERS External link
Filling date: 23 Sep 2025 Issue date: 19 Mar 2020
Application
Utility: PEPTIDES AND COMPOSITIONS FOR TREATMENT OF JOINT DAMAGE External link
Filling date: 23 Sep 2025 Issue date: 12 Mar 2020
Application
Utility: SYSTEMS AND METHODS FOR PULSED POSTERIOR VITREOUS DETACHMENT CREATION External link
Filling date: 23 Sep 2025 Issue date: 12 Mar 2020
Application
Utility: ANTIVIRAL PYRIDOPYRAZINEDIONE COMPOUNDS External link
Filling date: 23 Sep 2025 Issue date: 12 Mar 2020
Application
Utility: SURGICAL SYSTEMS INCLUDING A POWER LOSS MITIGATION SUBSYSTEM External link
Filling date: 23 Sep 2025 Issue date: 5 Mar 2020
Application
Utility: DEVICES AND METHODS FOR A CANNULA-DELIVERED TREATMENT MATERIAL APPLICATION DEVICE External link
Filling date: 23 Sep 2025 Issue date: 5 Mar 2020
Application
Utility: DOSAGE REGIMEN FOR AN ALPHA-ISOFORM SELECTIVE PHOSPHATIDYLINOSITOL 3-KINASE INHIBITOR External link
Filling date: 23 Sep 2025 Issue date: 5 Mar 2020
Application
Utility: PIERCING MECHANISM AND CARTRIDGE PIERCING SYSTEM External link
Filling date: 23 Sep 2025 Issue date: 5 Mar 2020
Application
Utility: Dosing schedule for a combination of Ceritinib and an anti-PD-1 antibody molecule External link
Filling date: 23 Sep 2025 Issue date: 5 Mar 2020
Application
Utility: SYSTEM FOR USE OF A PHARMACEUTICAL PRODUCT External link
Filling date: 23 Sep 2025 Issue date: 5 Mar 2020
Application
Utility: METHODS FOR PREPARING SQUALENE External link
Filling date: 23 Sep 2025 Issue date: 27 Feb 2020
Application
Utility: METHOD AND APPARATUS FOR PERFORMING OPHTHALMIC PROCEDURES REMOVING UNDESIRABLE FEATURES USING LASER ENERGY External link
Filling date: 23 Sep 2025 Issue date: 27 Feb 2020
Application
Utility: METHODS OF ENHANCING IMMUNE RESPONSE External link
Filling date: 23 Sep 2025 Issue date: 27 Feb 2020
Application
Utility: Drug Delivery Systems External link
Filling date: 23 Sep 2025 Issue date: 27 Feb 2020
Application
Utility: CHIMERIC ANTIGEN RECEPTOR THERAPY CHARACTERIZATION ASSAYS AND USES THEREOF External link
Filling date: 23 Sep 2025 Issue date: 27 Feb 2020
Application
Utility: Method of Adjuvant Cancer Treatment External link
Filling date: 23 Sep 2025 Issue date: 20 Feb 2020
Application
Utility: METHODS OF ENHANCING IMMUNE RESPONSE External link
Filling date: 23 Sep 2025 Issue date: 20 Feb 2020
Application
Utility: PHARMACEUTICAL DOSAGE FORMS External link
Filling date: 23 Sep 2025 Issue date: 20 Feb 2020
Application
Utility: LOW, IMMUNE ENHANCING, DOSE MTOR INHIBITORS AND USES THEREOF External link
Filling date: 23 Sep 2025 Issue date: 20 Feb 2020
Application
Utility: CELLS EXPRESSING A BCMA-TARGETING CHIMERIC ANTIGEN RECEPTOR, AND COMBINATION THERAPY WITH A GAMMA SECRETASE INHIBITOR External link
Filling date: 23 Sep 2025 Issue date: 20 Feb 2020
Application
Utility: TREATMENT REGIMENS External link
Filling date: 23 Sep 2025 Issue date: 20 Feb 2020
Application
Utility: LIPOSOMAL FORMULATION FOR USE IN THE TREATMENT OF CANCER External link
Filling date: 23 Sep 2025 Issue date: 20 Feb 2020
Application
Utility: DUAL OPTIC, CURVATURE CHANGING ACCOMMODATIVE IOL External link
Filling date: 23 Sep 2025 Issue date: 13 Feb 2020
Application
Utility: COMPOSITIONS AND METHODS FOR ANTIBODIES TARGETING EPO External link
Filling date: 23 Sep 2025 Issue date: 13 Feb 2020
Application
Utility: CYCLODEXTRIN-BASED POLYMERS FOR THERAPEUTIC DELIVERY External link
Filling date: 23 Sep 2025 Issue date: 13 Feb 2020
Application
Utility: Novel Heterocyclic Derivatives and Their Use in the Treatment of Neurological Disorders External link
Filling date: 23 Sep 2025 Issue date: 13 Feb 2020
Application
Utility: SHP INHIBITOR COMPOSITIONS AND USES FOR CHIMERIC ANTIGEN RECEPTOR THERAPY External link
Filling date: 23 Sep 2025 Issue date: 13 Feb 2020
Application
Utility: METHOD OF PREDICTING RESPONSE TO IMMUNOTHERAPY External link
Filling date: 23 Sep 2025 Issue date: 13 Feb 2020
Application
Utility: A Free Base Oxazine Derivative in Crystalline Form External link
Filling date: 23 Sep 2025 Issue date: 13 Feb 2020
Application
Utility: Chemical Process for Preparing Pyrimidine Derivatives and Intermediates Thereof External link
Filling date: 23 Sep 2025 Issue date: 6 Feb 2020
Application
Utility: Systems and methods for intra-ocular lens advancement External link
Filling date: 23 Sep 2025 Issue date: 6 Feb 2020
Application
Utility: COMBINATION THERAPIES External link
Filling date: 23 Sep 2025 Issue date: 30 Jan 2020
Application
Utility: PROCESS FOR PREPARING 1-(4-METHANESULFONYL-2-TRIFLUOROMETHYL-BENZYL)-2-METHYL-1H-PYRROLO [2,3-B]PYRIDIN-3-YL-ACETIC ACID External link
Filling date: 23 Sep 2025 Issue date: 30 Jan 2020
Application
Utility: AMATOXIN DERIVATIVES AND CONJUGATES THEREOF AS INHIBITORS OF RNA POLYMERASE External link
Filling date: 23 Sep 2025 Issue date: 23 Jan 2020
Application
Utility: Use of 2-carboxamide cycloamino urea derivatives in the treatment of EGFR dependent diseases or diseases that have acquired resistance to agents that target EGFR family members External link
Filling date: 23 Sep 2025 Issue date: 23 Jan 2020
Application
Utility: OPTIMIZATION OF SPHERICAL ABERRATION PARAMETERS FOR CORNEAL LASER TREATMENT External link
Filling date: 23 Sep 2025 Issue date: 23 Jan 2020
Application
Utility: SILICONE HYDROGEL LENSES WITH WATER-RICH SURFACES External link
Filling date: 23 Sep 2025 Issue date: 16 Jan 2020
Application
Utility: PET Imaging Agents External link
Filling date: 23 Sep 2025 Issue date: 16 Jan 2020
Application
Utility: COMPOUNDS CONTAINING S-N-VALERYL-N-{[2'-(1H-TETRAZOLE-5-YL)-BIPHENYL-4-YL]-METHYL}-VALINE AND (2R,4S)-5-BIPHENYL-4-YL-4-(3-CARBOXY-PROPIONYLAMINO)-2-METHYL-PENTANOIC ACID ETHYL ESTER MOIETIES AND CATIONS External link
Filling date: 23 Sep 2025 Issue date: 16 Jan 2020
Application
Utility: COMPOUNDS CONTAINING S-N-VALERYL-N-{[2'-(1H-TETRAZOLE-5-YL)-BIPHENYL-4-YL]-METHYL}-VALINE AND (2R,4S)-5-BIPHENYL-4-YL-4-(3-CARBOXY-PROPIONYLAMINO)-2-METHYL-PENTANOIC ACID ETHYL ESTER MOIETIES AND CATIONS External link
Filling date: 23 Sep 2025 Issue date: 16 Jan 2020
Application
Utility: 3-(5-HYDROXY-1-OXOISOINDOLIN-2-YL)PIPERIDINE-2,6-DIONE DERIVATIVES AND USES THEREOF External link
Filling date: 23 Sep 2025 Issue date: 16 Jan 2020

Showing 500 to 550 of 676 patents.